NCT02859597View on ClinicalTrials.gov

Use of High Flow Nasal Cannula During Sedation of Morbidly Obese Patients in the Endoscopy Suite

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 28, 2016

Primary Completion Date

September 28, 2018

Study Completion Date

September 28, 2018

Conditions
Morbid ObesityNoninvasive VentilationDeep Sedation
Interventions
DEVICE

High flow nasal cannula

High flow nasal cannula at 50 liters per minute and 50% oxygen will initially be used for oxygenation.

DEVICE

Nasal Cannula

Control group will receive oxygen via standard flow nasal cannula at 5 liters per minute (approximately an FiO2 of 0.35)

Trial Locations (1)

10467

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT02859597 - Use of High Flow Nasal Cannula During Sedation of Morbidly Obese Patients in the Endoscopy Suite | Biotech Hunter | Biotech Hunter